Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis

키워드

참고문헌 (76)

1. Munch A, "Microscopic colitis: clinical and pathologic perspectives", Clin Gastroenterol Hepatol, 13, pp.228~236 (2015)[DOI]
2. Fernandez-Banares F, "Epidemiology of microscopic colitis", Gut, 56, pp.1033~ (2007)
3. Gentile NM, "The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study", Clin Gastroenterol Hepatol, 12, pp.838~842 (2014)[DOI]
4. Pardi DS, "The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota", Gut, 56, pp.504~508 (2007)[DOI]
5. Bonderup OK, "The epidemiology of microscopic colitis: a 10-year pathologybased nationwide Danish cohort study", Scand J Gastroenterol, 50, pp.393~398 (2015)[DOI]
6. Fernandez-Banares F, "Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study", Inflamm Bowel Dis, 17, pp.1015~1020 (2011)[DOI]
7. Tong J, "Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis", Am J Gastroenterol, 110, pp.265~276 (2015)[DOI]
8. Masclee GM, "Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs", Am J Gastroenterol, 110, pp.749~759 (2015)[DOI]
9. Nielsen OH, "Microscopic colitis: a missed diagnosis", Lancet, 364, pp.2055~2057 (2004)[DOI]
10. Beaugerie L, "Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature", Aliment Pharmacol Ther, 22, pp.277~284 (2005)[DOI]
11. Fernandez-Banares F, "Drug consumption and the risk of microscopic colitis", Am J Gastroenterol, 102, pp.324~330 (2007)[DOI]
12. Bonderup OK, "Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases", Inflamm Bowel Dis, 20, pp.1702~1707 (2014)[DOI]
13. Casella G, "Colonic left-side increase of eosinophils: a clue to drug-related colitis in adults", Aliment Pharmacol Ther, 29, pp.535~541 (2009)[DOI]
14. Gleeson MH, "Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study", Aliment Pharmacol Ther, 17, pp.817~825 (2003)[DOI]
15. Levy AM, "Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis", Am J Gastroenterol, 96, pp.1522~1528 (2001)[DOI]
16. Mahid SS, "Smoking and inflammatory bowel disease: a meta-analysis", Mayo Clin Proc, 81, pp.1462~1471 (2006)[DOI]
17. Yen EF, "Current and past cigarette smoking significantly increase risk for microscopic colitis", Inflamm Bowel Dis, 18, pp.1835~1841 (2012)[DOI]
18. Vigren L, "Is smoking a risk factor for collagenous colitis", Scand J Gastroenterol, 46, pp.1334~1339 (2011)[DOI]
19. Munch A, "Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis group", J Crohns Colitis, 6, pp.932~945 (2012)[DOI]
20. Pardi DS, "Microscopic colitis", Gastroenterology, 140, pp.1155~1165 (2011)[DOI]
21. O'Toole A, "Optimal management of collagenous colitis: a review", Clin Exp Gastroenterol, 9, pp.31~39 (2016)
22. Bjornbak C, "Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups", Aliment Pharmacol Ther, 34, pp.1225~1234 (2011)[DOI]
23. Storr MA, "Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013", ISRN Gastroenterol, 2013, pp.352718~ (2013)
24. Kamp EJ, "Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 14, pp.659~668 (2016)[DOI]
25. Abboud R, "Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study", Inflamm Bowel Dis, 19, pp.550~553 (2013)[DOI]
26. Macaigne G, "Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study", Am J Gastroenterol, 109, pp.1461~1470 (2014)[DOI]
27. Hjortswang H, "Defining clinical criteria for clinical remission and disease activity in collagenous colitis", Inflamm Bowel Dis, 15, pp.1875~1881 (2009)[DOI]
28. Cotter TG, "Development of a microscopic colitis disease activity index: a prospective cohort study", Gut, 67, pp.441~446 (2018)[DOI]
29. Pisani LF, "Microscopic colitis: what do we know about pathogenesis", Inflamm Bowel Dis, 22, pp.450~458 (2016)[DOI]
30. Bo-Linn GW, "An evaluation of the significance of microscopic colitis in patients with chronic diarrhea", J Clin Invest, 75, pp.1559~1569 (1985)[DOI]
31. Burgel N, "Mechanisms of diarrhea in collagenous colitis", Gastroenterology, 123, pp.433~443 (2002)[DOI]
32. Stampfl DA, "Collagenous colitis: pathophysiologic considerations", Dig Dis Sci, 36, pp.705~711 (1991)[DOI]
33. Protic M, "Mechanism of diarrhea in microscopic colitis", World J Gastroenterol, 11, pp.5535~5539 (2005)[DOI]
34. Bohr J, "Effect of fasting on diarrhoea in collagenous colitis", Digestion, 65, pp.30~34 (2002)[DOI]
35. Lee E, "Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis", Gastroenterology, 103, pp.1790~1796 (1992)[DOI]
36. Ung KA, "Role of bile acids and bile acid binding agents in patients with collagenous colitis", Gut, 46, pp.170~175 (2000)[DOI]
37. Zeroogian JM, "Collagenous colitis and lymphocytic colitis", Annu Rev Med, 45, pp.105~118 (1994)[DOI]
38. Jarnerot G, "Faecal stream diversion in patients with collagenous colitis", Gut, 38, pp.154~155 (1996)
39. Veress B, "Microscopic colitis syndrome", Gut, 36, pp.880~886 (1995)[DOI]
40. Andresen L, "Activation of nuclear factor kappabeta in colonic mucosa from patients with collagenous and ulcerative colitis", Gut, 54, pp.503~509 (2005)[DOI]
41. Bohr J, "Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients", Gut, 39, pp.846~851 (1996)[DOI]
42. Stewart M, "The association of coeliac disease and microscopic colitis: a large population-based study", Aliment Pharmacol Ther, 33, pp.1340~1349 (2011)[DOI]
43. Green PH, "An association between microscopic colitis and celiac disease", Clin Gastroenterol Hepatol, 7, pp.1210~1216 (2009)[DOI]
44. Park T, "Microscopic colitis: a review of etiology, treatment and refractory disease", World J Gastroenterol, 21, pp.8804~8810 (2015)[DOI]
45. Koskela RM, "Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis", Eur J Gastroenterol Hepatol, 20, pp.276~282 (2008)[DOI]
46. Fernandez-Banares F, "Predisposing HLADQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis", Eur J Gastroenterol Hepatol, 17, pp.1333~1338 (2005)[DOI]
47. Fine KD, "High prevalence of celiac spruelike HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome", Am J Gastroenterol, 95, pp.1974~1982 (2000)[DOI]
48. Garner C, "Genome-wide association study of celiac disease in North America confirms FRMD4B as new celiac locus", PLoS One, 9, pp.e101428~ (2014)[DOI]
49. ASGE Standards of Practice Committee, "Endoscopic mucosal tissue sampling", Gastrointest Endosc, 78, pp.216~224 (2013)[DOI]
50. Langner C, "Histology of microscopic colitis-review with a practical approach for pathologists", Histopathology, 66, pp.613~626 (2015)[DOI]
51. Fiehn AM, "Observer variability in the histopathologic diagnosis of microscopic colitis and subgroups", Hum Pathol, 44, pp.2461~2466 (2013)[DOI]
52. Ayata G, "Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis", Am J Surg Pathol, 26, pp.1414~1423 (2002)[DOI]
53. Mahajan D, "Lymphocytic colitis and collagenous colitis: a review of clinicopathologic features and immunologic abnormalities", Adv Anat Pathol, 19, pp.28~38 (2012)[DOI]
54. Carmack SW, "Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist", Adv Anat Pathol, 16, pp.290~306 (2009)[DOI]
55. Yen EF, "Review article: microscopic colitis--lymphocytic, collagenous and ‘mast cell' colitis", Aliment Pharmacol Ther, 34, pp.21~32 (2011)[DOI]
56. Limsui D, "Observer variability in the histologic diagnosis of microscopic colitis", Inflamm Bowel Dis, 15, pp.35~38 (2009)[DOI]
57. Bonderup OK, "Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis", Gut, 52, pp.248~251 (2003)[DOI]
58. Miehlke S, "Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial", Gastroenterology, 123, pp.978~984 (2002)[DOI]
59. Yen EF, "Review of the microscopic colitides", Curr Gastroenterol Rep, 13, pp.458~464 (2011)[DOI]
60. Bonderup OK, "Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial", Gut, 58, pp.68~72 (2009)[DOI]
61. Miehlke S, "Oral budesonide for maintenance treatment of collagenous colitis: a randomized, doubleblind, placebo-controlled trial", Gastroenterology, 135, pp.1510~1516 (2008)[DOI]
62. Hjortswang H, "Health-related quality of life is impaired in active collagenous colitis", Dig Liver Dis, 43, pp.102~109 (2011)[DOI]
63. Madisch A, "Oral budesonide therapy improves quality of life in patients with collagenous colitis", Int J Colorectal Dis, 20, pp.312~316 (2005)[DOI]
64. Munch A, "Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial", Gut, 65, pp.47~56 (2016)[DOI]
65. Yen EF, "Non-IBD colitides (eosinophilic, microscopic)", Best Pract Res Clin Gastroenterol, 26, pp.611~622 (2012)
66. Amaro R, "Collagenous colitis treated successfully with bismuth subsalicylate", Dig Dis Sci, 45, pp.1447~1450 (2000)[DOI]
67. Fine KD, "Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis", Gastroenterology, 114, pp.29~36 (1998)[DOI]
68. Olesen M, "Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients", Gut, 53, pp.536~541 (2004)[DOI]
69. Gentile NM, "Outcomes of patients with microscopic colitis treated with corticosteroids: a populationbased study", Am J Gastroenterol, 108, pp.256~259 (2013)[DOI]
70. Miehlke S, "Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide", Aliment Pharmacol Ther, 22, pp.1115~1119 (2005)[DOI]
71. Stewart MJ, "Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis", Clin Gastroenterol Hepatol, 9, pp.881~890 (2011)[DOI]
72. Pardi DS, "Lymphocytic colitis: clinical features, treatment, and outcomes", Am J Gastroenterol, 97, pp.2829~2833 (2002)[DOI]
73. Pardi DS, "Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine", Gastroenterology, 120, pp.1483~1484 (2001)[DOI]
74. Riddell J, "Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes", J Gastroenterol Hepatol, 22, pp.1589~1593 (2007)[DOI]
75. Munch A, "Lack of effect of methotrexate in budesonide-refractory collagenous colitis", Clin Exp Gastroenterol, 6, pp.149~152 (2013)
76. Esteve M, "Efficacy of anti-TNF therapies in refractory severe microscopic colitis", J Crohns Colitis, 5, pp.612~618 (2011)[DOI]

관련 논문AI추천